
AIM ImmunoTech Inc.
AIMNYSECIK 946644HealthcareFiscal year ends Dec 31
Reports and events: 417 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-1417:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-028610 |
| 2023-08-0716:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-204985 |
| 2023-07-2717:01 ET | SC 13D | Ownership report, active investor | 0001193125-23-196184 |
| 2023-07-1016:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-024125 |
| 2023-06-2714:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-022594 |
| 2023-05-3007:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-019393 |
| 2023-05-1518:30 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-016763 |
| 2023-04-1916:45 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-012921 |
| 2023-04-0716:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-011560 |
| 2023-03-3116:42 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-010351 |
| 2023-03-3008:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-23-009606 |
| 2023-03-1608:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007841 |
| 2023-03-1308:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-007353 |
| 2023-03-0808:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-006977 |
| 2023-03-0608:50 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-006744 |
| 2023-02-2415:06 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-23-005961 |
| 2023-02-1016:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-004312 |
| 2023-02-0607:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-003624 |
| 2023-01-1708:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-001536 |
| 2022-11-1416:34 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032118 |
| 2022-11-0908:45 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-031043 |
| 2022-09-0916:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-025491 |
| 2022-08-1508:00 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022600 |
| 2022-07-1808:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-019534 |
| 2022-06-2108:35 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-017273 |
| 2022-06-1709:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-017052 |
| 2022-05-1316:32 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-013341 |
| 2022-04-1207:47 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-009656 |
| 2022-03-3113:05 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-008324 |
| 2022-03-2808:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-007813 |
| 2022-03-1607:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-006933 |
| 2022-03-0708:05 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-006141 |
| 2022-03-0308:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-22-005894 |
| 2022-01-2713:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-002382 |
| 2022-01-2609:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-002248 |
| 2022-01-2408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-22-002053 |
| 2021-12-0907:20 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-030891 |
| 2021-11-1516:34 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028650 |
| 2021-10-0717:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-024968 |
| 2021-10-0607:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-024737 |
| 2021-09-3006:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-21-024139 |
| 2021-09-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-21-023270 |
| 2021-09-1707:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-022966 |
| 2021-08-1716:30 ET | 10-Q/A | Quarterly report, amendedPeriod 2021-06-30 | 0001493152-21-020453 |
| 2021-08-1716:30 ET | DEF 14A | Proxy statementPeriod 2021-08-17 | 0001493152-21-020454 |
| 2021-08-1616:51 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-020230 |
| 2021-07-1410:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-016808 |
| 2021-07-1308:00 ET | 8-K | 1.01 Entry into a material agreement | 0001493152-21-016676 |
| 2021-06-1407:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-014224 |
| 2021-05-2708:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-013029 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:22 ET. Listed shows no prices and gives no investment advice.